Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Probiotic supplementation for anxiety symptoms in people with Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
Npj Parkinson S Disease
December 2026
Lam J.S.T.
Open Access
Gerobiotics and neuroprotection: effects on the gut-brain axis in age-related neurodegenerative diseases
Frontiers in Aging Neuroscience
28 May 2026
Kocaadam-Bozkurt B.
Open Access
The Role of Probiotics in Parkinson’s Disease–Current Evidence and Future Perspectives
Journal of Dietary Supplements
2026
Dadak Yıldırım E.
Dopamine and the Gut Microbiota: Interactions Within the Microbiota–Gut–Brain Axis and Therapeutic Perspectives
International Journal of Molecular Sciences
January 2026
Barbu A.C.
Open Access
Non-Gastrointestinal Effect of Probiotics in Patients with Parkinson's Disease: A Systematic Review of Randomized Controlled Trials
Current Nutrition and Food Science
2026
Tec-Ojeda A.G.
Lactiplantibacillus plantarum as a Psychobiotic Strategy Targeting Parkinson’s Disease: A Review and Mechanistic Insights
Nutrients
October 2025
Chen W.L.
Open Access
Gut Microbiome as a Source of Probiotic Drugs for Parkinson’s Disease
International Journal of Molecular Sciences
October 2025
Poluektova E.U.
Open Access
Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson’s disease
Inflammopharmacology
July 2025
Ramadan M.E.
Open Access
Targeting gut microbiota as a therapeutic approach for neurodegenerative diseases
Neuroprotection
June 2025
Olajide T.S.
Open Access
The effect of diet on Parkinson's disease progression, symptoms and severity: A review of randomised controlled trials
Proceedings of the Nutrition Society
2025
Prasad A.
Open Access
Comparative efficacy of non-pharmacological interventions for Parkinson’s disease with constipation: a systematic review and network meta-analysis
Frontiers in Neurology
2025
Zhang P.
Open Access
Probiotics as Potential Treatments for Neurodegenerative Diseases: a Review of the Evidence from in vivo to Clinical Trial
Biomolecules and Therapeutics
Jan 2025
Kim J.H.
Open Access
Efficacy of gut microbiota-targeted therapies in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials
Frontiers in Cellular and Infection Microbiology
2025
Gu X.
Open Access
Therapeutic role of probiotics in motor and non-motor symptoms of Parkinson’s disease
Exploration of Neuroprotective Therapy
2025
Páez-García S.
Open Access
The Role of the Gastrointestinal Microbiota in Parkinson’s Disease
Biomolecules
January 2025
Gabrielli M.
Open Access
Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics
Journal of Parkinson S Disease
15 October 2024
Hor J.W.
Open Access
Microbiome-based therapeutics for Parkinson's disease
Neurotherapeutics
October 2024
Hamilton A.M.
Open Access
The effect of crocin on movement disorders and oxidative DNA damage in Parkinson's disease: Insights from a randomized controlled trial
Parkinsonism and Related Disorders
September 2024
Mohammad Soleymani S.
Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review
Clinical Nutrition
July 2024
Mincic A.M.
Open Access
Efficacy of probiotic supplements on Parkinson's disease: A systematic review and meta-analysis
Complementary Therapies in Medicine
June 2024
Jin X.
Open Access
Parkinson's disease from an Ayurveda perspective: Opportunities and challenges for further research
Translational Models of Parkinson S Disease and Related Movement Disorders
1 January 2024
Kulkarni S.P.